Spinal interleukin-10 therapy to treat peripheral neuropathic pain
about
The search for novel analgesics: targets and mechanismsMesoporous silica-supported lipid bilayers (protocells) for DNA cargo delivery to the spinal cord.Improvement of spinal non-viral IL-10 gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain.Monocytes/Macrophages control resolution of transient inflammatory pain.Spinal Cord T-Cell Infiltration in the Rat Spared Nerve Injury Model: A Time Course Study.Optogenetic and chemogenetic strategies for sustained inhibition of pain.Neuropathic pain and cytokines: current perspectives.Modulating the delicate glial-neuronal interactions in neuropathic pain: promises and potential caveats.Preclinical toxicity evaluation of AAV for pain: evidence from human AAV studies and from the pharmacology of analgesic drugs.The neuroprotective effect exerted by oligodendroglial progenitors on ischemically impaired hippocampal cells.Cerebrospinal Fluid Cytokines and Neurotrophic Factors in Human Chronic Pain Populations: A Comprehensive Review.Current and Future Issues in the Development of Spinal Agents for the Management of Pain.Ex vivo nonviral gene delivery of μ-opioid receptor to attenuate cancer-induced pain.High cerebrospinal fluid levels of interleukin-10 attained by AAV in dogs.Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.Effects of spinal non-viral interleukin-10 gene therapy formulated with d-mannose in neuropathic interleukin-10 deficient mice: Behavioral characterization, mRNA and protein analysis in pain relevant tissues.St. John's wort treatment in women bears risks beyond pharmacokinetic drug interactions.Morin Suppresses Astrocyte Activation and Regulates Cytokine Release in Bone Cancer Pain Rat Models.HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy.Lipopolysaccharide from Rhodobacter sphaeroides (TLR4 antagonist) attenuates hypersensitivity and modulates nociceptive factors.Anti-nociceptive and anti-inflammatory actions of sulforaphane in chronic constriction injury-induced neuropathic pain mice.Differential mRNA expression of neuroinflammatory modulators in the spinal cord and thalamus of type 2 diabetic monkeys.Chronic Pain in Inflammatory Arthritis: Mechanisms, Metrology, and Emerging Targets-A Focus on the JAK-STAT Pathway.Conditioned Medium of Bone Marrow-Derived Mesenchymal Stromal Cells as a Therapeutic Approach to Neuropathic Pain: A Preclinical Evaluation.Bone marrow-derived mesenchymal stem/stromal cells reverse the sensorial diabetic neuropathy via modulation of spinal neuroinflammatory cascades.Kartogenin inhibits pain behavior, chondrocyte inflammation, and attenuates osteoarthritis progression in mice through induction of IL-10Amelioration of spinal cord injury in rats by blocking peroxynitrite/calpain activity
P2860
Q24288817-7EB69067-9179-4231-8302-59379E04DCAEQ33581344-AABC9E2A-473E-4615-B3F8-5B2B1F28062DQ33713080-C09F3BEA-B1EF-4102-A0F7-C5509059780BQ33823432-B9AF3667-95F2-40BE-8018-364AAC511FB9Q36743645-5C8514E1-6DCB-4561-8AE0-700D33DF3726Q37147972-7B8D4E73-56B0-4D8A-A0F8-72CA220327F7Q38167771-9E6637AB-BC8C-44F1-B75B-9766F5148681Q38211273-7E15F07D-7838-4171-BA57-E9AA3E84532AQ38245677-ECC5B8F6-C895-42D7-BD1F-7D527E9327E1Q38256533-5704C260-4468-4E7A-9B2D-DFD0BEDBFAC5Q38263540-99547A31-1457-4940-9801-AB5BCF89D097Q38727831-E24C935D-8DE5-4BBF-8F4D-D35E0B7B6162Q40378943-B09E76E8-9770-41F4-A087-4670B1183C47Q41575309-96511FDD-FF4D-4CC9-8827-7857B86363C3Q43075742-AB90F85F-A76D-4419-95CB-997C66507EB3Q45874115-A1F65E47-7322-4B8C-B459-92148FC4F7F2Q48188509-E16FAE14-5E71-42FF-A6DF-B875A7B56B14Q48271894-5702A657-2E15-4C02-8970-B912694BC599Q50858728-2FA92B47-D128-4557-B63F-3CD3EE8002DFQ53410445-BF9A703F-D12B-4E7C-8F3C-AA8833D37172Q53537071-97AADB37-031F-434B-BA71-EF371DF2482CQ54089317-915FC2CC-6A7B-4965-8740-01E02D8D0136Q55027042-587F841B-51D2-46FC-BEA3-9FBA3C215989Q55278639-21331519-2ED7-495F-BF31-A792C94F64FBQ55460211-DC054301-4DE9-46CB-B4E2-6F73235854A1Q58740651-19B860B5-FB1E-4408-9939-A21139D275B5Q58786337-6BB7CB6F-1AAB-44A5-9CCA-96D503A1CCF8
P2860
Spinal interleukin-10 therapy to treat peripheral neuropathic pain
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Spinal interleukin-10 therapy to treat peripheral neuropathic pain
@ast
Spinal interleukin-10 therapy to treat peripheral neuropathic pain
@en
Spinal interleukin-10 therapy to treat peripheral neuropathic pain
@nl
type
label
Spinal interleukin-10 therapy to treat peripheral neuropathic pain
@ast
Spinal interleukin-10 therapy to treat peripheral neuropathic pain
@en
Spinal interleukin-10 therapy to treat peripheral neuropathic pain
@nl
prefLabel
Spinal interleukin-10 therapy to treat peripheral neuropathic pain
@ast
Spinal interleukin-10 therapy to treat peripheral neuropathic pain
@en
Spinal interleukin-10 therapy to treat peripheral neuropathic pain
@nl
P2093
P2860
P921
P3181
P1433
P1476
Spinal interleukin-10 therapy to treat peripheral neuropathic pain
@en
P2093
Erin D. Milligan
Kathryn R. Penzkover
Melissa J. Mahoney
Ryan G. Soderquist
P2860
P304
520-6; discussion 526
P3181
P356
10.1111/J.1525-1403.2012.00462.X
P407
P577
2012-01-01T00:00:00Z